Michael Cain

835 total citations
15 papers, 673 citations indexed

About

Michael Cain is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael Cain has authored 15 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 8 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael Cain's work include Synthesis and pharmacology of benzodiazepine derivatives (7 papers), Synthesis and bioactivity of alkaloids (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). Michael Cain is often cited by papers focused on Synthesis and pharmacology of benzodiazepine derivatives (7 papers), Synthesis and bioactivity of alkaloids (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). Michael Cain collaborates with scholars based in United States. Michael Cain's co-authors include James A. Bristol, Ronald E. Weishaar, Phil Skolnick, Steven M. Paul, James M. Cook, Kenner C. Rice, Jacqueline N. Crawley, Robert Weber, Steven A. Barker and Margaret M. Schweri and has published in prestigious journals such as Science, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Michael Cain

15 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Cain United States	11	417	275	224	76	56	15	673
Vilma Ruperto United States	11	500 1.2×	215 0.8×	498 2.2×	57 0.8×	48 0.9×	19	863
Joachim Mierau Germany	13	266 0.6×	147 0.5×	294 1.3×	56 0.7×	59 1.1×	22	743
Carol Smith United States	17	445 1.1×	220 0.8×	321 1.4×	118 1.6×	23 0.4×	20	796
Michel Langlois France	18	571 1.4×	329 1.2×	461 2.1×	73 1.0×	71 1.3×	41	1.0k
Sham S. Nikam United States	18	339 0.8×	310 1.1×	207 0.9×	42 0.6×	75 1.3×	28	696
Piero Angeli Italy	14	365 0.9×	179 0.7×	196 0.9×	73 1.0×	41 0.7×	56	593
Michio Terai United Kingdom	11	362 0.9×	75 0.3×	240 1.1×	69 0.9×	99 1.8×	24	613
Virginia L. Lucaites United States	19	491 1.2×	217 0.8×	577 2.6×	77 1.0×	117 2.1×	24	997
Carol B. Fox United States	14	445 1.1×	170 0.6×	347 1.5×	112 1.5×	74 1.3×	19	695
Robert M. DeMarinis United States	17	452 1.1×	214 0.8×	285 1.3×	44 0.6×	102 1.8×	41	750

Countries citing papers authored by Michael Cain

Since Specialization

Citations

This map shows the geographic impact of Michael Cain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Cain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Cain more than expected).

Fields of papers citing papers by Michael Cain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Cain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Cain. The network helps show where Michael Cain may publish in the future.

Co-authorship network of co-authors of Michael Cain

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Cain. A scholar is included among the top collaborators of Michael Cain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Cain. Michael Cain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Cain, Michael, et al.. (2000). The quantum leap :tools for managing companies in the new economy. Medical Entomology and Zoology. 2 indexed citations

Cain, Michael, David J. Brown, Ashok K. Gupta, et al.. (1998). A Scalable Process for the Novel Antidepressant ABT-200. Organic Process Research & Development. 2(6). 351–356. 20 indexed citations

Klix, Russell C., et al.. (1995). Synthesis of 5,6-methylenedioxy-1-tetralone. An aryl grignard approach from guaiacol. Tetrahedron Letters. 36(36). 6413–6414. 12 indexed citations

Sircar, Ila, et al.. (1986). Cardiotonic agents. 4. Synthesis and biological evaluation of N-substituted 2,4,4a,5-tetrahydro-3H-indeno[1,2-c]pyridazin-3-ones: rigid structures derived from CI-930 and analogs. Journal of Medicinal Chemistry. 29(11). 2142–2148. 19 indexed citations

Weishaar, Ronald E., Michael Cain, & James A. Bristol. (1985). A New Generation of Phosphodiesterase Inhibitors: Multiple Molecular Forms of Phosphodiesterase and the Potential for Drug Selectivity. Journal of Medicinal Chemistry. 28(5). 537–545. 216 indexed citations

Guzman, Filadelfo, Michael Cain, Timothy J. Hagen, et al.. (1984). Biomimetic approach to potential benzodiazepine receptor agonists and antagonists. Journal of Medicinal Chemistry. 27(5). 564–570. 44 indexed citations

Cain, Michael, Robert Weber, J. M. Cook, et al.. (1983). ChemInform Abstract: β‐CARBOLINES: SYNTHESIS AND NEUROCHEMICAL AND PHARMACOLOGICAL ACTIONS ON BRAIN BENZODIAZEPINE RECEPTORS. Chemischer Informationsdienst. 14(5). 16 indexed citations

Mendelson, Wallace B., Michael Cain, James M. Cook, Steven M. Paul, & Phil Skolnick. (1983). A Benzodiazepine Receptor Antagonist Decreases Sleep and Reverses the Hypnotic Actions of Flurazepam. Science. 219(4583). 414–416. 46 indexed citations

Cain, Michael, Robert Weber, James M. Cook, et al.. (1982). .beta.-Carbolines: synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptors. Journal of Medicinal Chemistry. 25(9). 1081–1091. 156 indexed citations

10.

Cain, Michael, et al.. (1982). Do benzodiazepine receptors play a role in sleep regulation? Studies with the benzodiazepine antagonist, 3-hydroxymethyl-beta-carboline (3-HMC).. PubMed. 90. 253–61. 9 indexed citations

11.

Skolnick, Phil, Evan F. Williams, J. M. Cook, et al.. (1982). beta-Carbolines and benzodiazepine receptors: structure-activity relationships and pharmacologic activity.. PubMed. 90. 233–52. 8 indexed citations

12.

Cook, James M., et al.. (1982). Biomimetic Approach to Potential Benzodiazepine Agonists and Antagonists. Heterocycles. 19(6). 1003–1003. 9 indexed citations

13.

Schweri, Margaret M., Michael Cain, James M. Cook, Steven M. Paul, & Phil Skolnick. (1982). Blockade of 3-carbomethoxy-β-carboline induced seizures by diazepam and the benzodiazepine antagonists, Ro 15-1788 and CGS 8216. Pharmacology Biochemistry and Behavior. 17(3). 457–460. 62 indexed citations

14.

Skolnick, Phil, Steven M. Paul, Jacqueline N. Crawley, et al.. (1981). 3-Hydroxymethyl-β-carboline antagonizes some pharmacologic actions of diazepam. European Journal of Pharmacology. 69(4). 525–527. 39 indexed citations

15.

Williams, Evan F., Steven M. Paul, Kenner C. Rice, Michael Cain, & Phil Skolnick. (1981). Binding of [³H]ethyl‐β‐carboline‐3‐carboxylate to brain benzodiazepine receptors. FEBS Letters. 132(2). 269–272. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact